Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Heart Defect Closure Device Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent times, there’s been a swift expansion in the heart defect closure device market. It is projected to rise from $1.11 billion in 2024 to approximately $1.27 billion in 2025, experiencing a compound annual growth rate (CAGR) of 13.8%. Factors contributing to this growth during the historical period include an increase in congenital heart issues, an aging population, heightened health consciousness, elevated research and development activities, and advancements in catheterization methodologies.

The market size of heart defect closure devices is projected to experience significant growth in the forthcoming years, rising to a whopping $2.12 billion by 2029 with a compound annual growth rate (CAGR) of 13.7%. This anticipated growth during the prediction period is mainly due to an increase in congenital defects, enhancements in diagnostic techniques, a surge in the adoption of MRI procedures, an increase in the utilization of 3D imaging in heart defect closure operations, and a high prevalence of ischemic stroke. Key trends anticipated during the forecast period include technological progress, the creation of cutting-edge products, the development of next-generation heart closure devices, the increasing identification of PFO closure devices, and the necessity to examine the advantages of PFO closure for the elderly demographic.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16074&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Heart Defect Closure Device Market?

The escalating incidence of congenital heart issues is predicted to fuel the expansion of the heart defect closure device market in the future. These congenital heart issues are structural anomalies in the heart that one is born with. The surge in congenital heart problems can be attributed to genetic factors, environmental impacts, and maternal health conditions such as diabetes, obesity, and exposure to specific medications or infections during pregnancy. Heart defect closure devices are beneficial in treating congenital heart problems as they provide minimally invasive solutions to close abnormal openings in the heart. This helps in reinstating normal blood flow, minimizing complications, and enhancing the overall functioning of the heart. For example, as per a report published in the National Library of Medicine (NLM) in October 2024, a research into US-based biomedical informatics and computational health data science highlighted a sudden increase in the CHD incidence rate to 5.46% in 2023, a steep rise from 1.12% in 2020, 2.36% in 2021, and 3.87% in 2022. Consequently, the increasing count of people suffering from congenital heart issues is the driving force behind the growth of the heart defect closure device market.

Which Key Market Segments Comprise the Heart Defect Closure Device Market and Drive Its Revenue Growth?

The heart defect closure devicemarket covered in this report is segmented –

1) By Type: Atrial Septal Defect (ASD) Closure Device, Left Atrial Appendage (LAA) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices

2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials

3) By Mode Of Delivery: Transcatheter Delivery, Surgical Delivery, Other Modes

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Atrial Septal Defect (ASD) Closure Device: Occluder Devices (Septal Occluders), Implantable Patch Devices, Self-Expanding Devices, Balloon-Expandable Devices

2) By Left Atrial Appendage (LAA) Closure Devices: Occluder Devices (WATCHMAN Device), Clip-Based Devices, Self-Expanding LAA Closure Devices

3) By Patent Foramen Ovale (PFO) Closure Devices: Septal Occluders, Self-Expanding Occluders, Balloon-Expandable Occluders

4) By Patent Ductus Arteriosus (PDA) Closure Devices: Coil-Based Closure Devices, Stent-Based Closure Devices, Amplatzer Occluders

5) By Ventricular Septal Defect (VSD) Closure Devices: Septal Occluder Devices, Balloon-Expandable Occluders, Self-Expanding Occluders

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16074&type=smp

Which Areas Are Leading Regions in the Heart Defect Closure Device Market Expansion Across the Globe?

North America was the largest region in the heart defect closure device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart defect closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theHeart Defect Closure Device Market Over the Coming Years?

Within the heart defect closure device market, major organizations are utilizing self-expandable, double-disc occluders to offer a less invasive alternative to seal heart defects. These occluders elevate the safety during procedures, enhance patient recovery times, and lower the chances of complications which are ordinary in conventional open-heart surgeries. An example of this development was seen in September 2022, when a medical devices and healthcare company from the US, Abbott Laboratories, launched their Amplatzer Talisman PFO Occlusion System in Europe. This device is specifically engineered to seal a patent foramen ovale (PFO) – an unsusual gap between the heart’s left and right atria, which might be the cause of strokes and additional complications. The procedure involves using the device to deploy a self-expandable, double-disc occluder made from nitinol wire mesh in a less invasive way to close the PFO, which helps in blocking any clot transfer between the atria.

View the full report here:

https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

How Is the Heart Defect Closure Device Market Conceptually Defined?

A heart defect closure device is a medical device used to close abnormal openings or defects in the heart’s structure, typically in the septum, which is the wall separating the heart’s chambers. It is used to treat certain heart defects, such as atrial septal defects or patent foramen ovale, by closing heart’s wall. They are delivered via minimally invasive procedures, providing an effective and less invasive alternative to open-heart surgery for patients with these conditions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16074

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model